Baker Brothers Advisors - ALIGOS THERAPEUTICS INC ownership

ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 47 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ALIGOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,551,071
-23.1%
2,076,4000.0%0.01%
-25.0%
Q2 2023$2,016,184
+11.1%
2,076,4000.0%0.01%
+20.0%
Q1 2023$1,814,774
-8.3%
2,076,4000.0%0.01%
-16.7%
Q4 2022$1,978,602
-13.4%
2,076,4000.0%0.01%
-20.0%
Q3 2022$2,284,000
-9.1%
2,076,4000.0%0.02%
+7.1%
Q2 2022$2,512,000
-43.7%
2,076,4000.0%0.01%
-46.2%
Q1 2022$4,464,000
-81.9%
2,076,4000.0%0.03%
-78.3%
Q4 2021$24,647,000
-23.5%
2,076,4000.0%0.12%
-14.9%
Q3 2021$32,205,000
-1.9%
2,076,400
+29.0%
0.14%
-2.1%
Q2 2021$32,820,000
-10.4%
1,610,0000.0%0.14%
-9.4%
Q1 2021$36,611,000
-17.8%
1,610,0000.0%0.16%
-5.4%
Q4 2020$44,517,0001,610,0000.17%
Other shareholders
ALIGOS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,320,381$27,543,00014.73%
Pivotal bioVenture Partners Investment Advisor LLC 876,548$10,405,0004.35%
Logos Global Management LP 3,112,785$36,949,0003.81%
Vivo Capital, LLC 3,547,030$42,103,0002.54%
Novo Holdings A/S 2,614,563$31,035,0001.47%
Boxer Capital, LLC 1,526,048$18,114,0000.70%
HHLR ADVISORS, LTD. 2,365,064$28,073,0000.43%
Cormorant Asset Management, LP 521,257$6,187,0000.37%
Baker Brothers Advisors 2,076,400$24,647,0000.12%
Sofinnova Investments, Inc. 127,791$1,517,0000.09%
View complete list of ALIGOS THERAPEUTICS INC shareholders